Navigation Links
Ariadne Genomics Announces the Release of PathwayStudio?Central, Client-Server Software for Biological Pathway Analysis

Ariadne Genomics, Inc. today announced the release of PathwayStudio?Central, client-server software for visualization and analysis of biological pathways and gene regulation networks for bio-medical research labs, biotechnology and pharmaceutical companies. PathwayStudio?Central is available for a free 20 day trial at www.ariadnegenomics.com.

PathwayStudio?Central builds pathways from microarray data, identifies biomarkers, and models drug responses. The software comes with ResNet?database of 500,000+ functional relationships and MedScan?tool for automatic extraction of information from scientific literature.

ResNet?database of functional relationships for human, rat and mouse contains 52,000 annotated mammalian proteins, 40,000 chemicals, and over 500 thousand total functional relationships, among which there are 42,000+ physical protein-protein interactions, 46,000+ facts of gene expression regulation, and about 160,000 links between 1779 human diseases and individual proteins.

ResNet was compiled with MedScan?unique Natural Language Processing (NLP)-based tool. MedScan?leverages hand-crafted dictionaries of protein and chemical names, and precise text parsing and pattern matching algorithms specifically developed for biological text analysis.

“PathwayStudio?Central helps scientists to keep current with literature using embedded MedScan information extraction tool that can “read?scientific text and extract functional relationships on the fly? said Ilya Mazo, President of Ariadne Genomics. “They can get an immediate view of all known relationships for a protein or a small molecule, build pathways from gene lists or results of PubMed searches, or predict networks from the gene expression data.?/p>

PathwayStudio?Central is a scalable solution that can be easily deployed in a lab or throughout an entire organization, enabling pathway data sharing and user rights management. Server-side network analysis algorithms and MedScan informat
'"/>

Source:PRWeb


Page: 1 2

Related biology news :

1. Advancements In Genomics Foster Deep Sea Discoveries
2. Genomics researchers discover protein deficit that causes drug toxicity
3. Genomics-based vaccine could prevent deadly cattle disease
4. Genomics throws species definition in question for microbes
5. FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
6. Improved Outcomes Releases GeneLinker(TM) Gold and Platinum Version 4.6
7. NIH Calls on Scientists to Speed Public Release of Research Publications
8. Affymetrix and Stratagene Announce Strategic Software Alliance
9. Software Tool for Converting Scientific Text into a Database of Functional Relationships
10. Software agents could help unmask reality of disease clusters
11. Software might revolutionize glucose monitoring in critically ill patients

Post Your Comments:
(Date:11/23/2009)...wa - The only swine vaccine available for the H1N1...ected with the virus. The vaccination marks the fi...gnosed with the pandemic flu., Iowa State Univer...eveloped the vaccine this summer and has been ship...Kansas and Illinois for several weeks., The late...
(Date:11/23/2009)... Ill. Two new studies reveal in unprecedented det...s to assemble new proteins and guide them toward t...used molecular dynamics flexible fitting (MDFF) to...prominent molecular partners. , The first study...ces , concerns the intimate signaling between the ...
(Date:11/23/2009)...al Institute of General Medical Sciences (NIGMS), ...s investing $42.3 million for grants in scientific..." NIH developed the GO grant program to stimulate ...ovided by the American Recovery and Reinvestment A...s that promise to have a significant impact on a f...
Breaking Biology News(10 mins):Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3SyntheMed Receives US Patent on Novel Polymer Technology 13286 1SyntheMed Receives US Patent on Novel Polymer Technology 13286 2Breakthrough Nursing Home Alternative Now Available to Cincinnati Elders and Their Families at Deupree Cottages 53216 1Breakthrough Nursing Home Alternative Now Available to Cincinnati Elders and Their Families at Deupree Cottages 53216 2Breakthrough Nursing Home Alternative Now Available to Cincinnati Elders and Their Families at Deupree Cottages 53216 3TriReme Medical Inc Receives CE Marking for Glider 28TM 29 PTCA Dilatation Catheter 53214 1TriReme Medical Inc Receives CE Marking for Glider 28TM 29 PTCA Dilatation Catheter 53214 2
...LA Research led by David Worthylake, PhD, Assista... at LSU Health Sciences Center New Orleans, may he...pound to prevent the spread of cancer. The researc...he Journal of Biological Chemistry . , During th...disease, cancer cells acquire the ability to detac...
...0 years it has become commonplace to think of Eart...tain equilibrium so that life might continue and f...ncient Greek goddess of Earth, even put forth the ...ganism, with its complex systems finely tuned to c...But actually it is the Gaia view that is out of ki...
...ms to forget things, will she end up demented? The...ms that may signal which 70-year-olds risk develop...t the Sahlgrenska Academy at the University of Got...y used to predict which elderly individuals risk d... The thesis shows that memory loss is the only fac...
Other Biology News:LSUHSC research describes function of key protein in cancer spread 2New book suggests Earth perhaps not such a benevolent mother after all 2New book suggests Earth perhaps not such a benevolent mother after all 3Early identification of dementia increasingly difficult 2
(Date:11/24/2009)... The FBI recently approved the Promega Pow...ipating in or generating DNA records for the Natio...adison, WI USA (PRWEB) -- The FBI recently approve...e by laboratories participating in, or generating ...IS). NDIS currently contains more than seven milli...
(Date:11/24/2009)...vember24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,...lcompany,today,announcedthatithassubmittedaMAAtoth...ompany,senzymereplacementtherapyindevelopment,fort...keting,applicationforvelaglucerasealfathathasbeens...andCanada. , Basedonaglobalsupplyshortageofth...
(Date:11/24/2009)...ly,November24/PRNewswire/--HealthRoboticstodayanno...groupofselected,investors.ThisrecentlyformedToront...csCanada,Inc.andwillmarket,install,andsupport,Heal...sthe,revolutionaryproductofferingsi.v.STATION(TM),...illalsoprovideassistanceonan"asneeded,basis"toitss...
(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--CellTherapeutics,Inc....21stAnnualPiperJaffrayHealthCareConference.Theconf...eHotel. ,, CTIwillpresentonTuesday,December1at1...ebcastofCTI,spresentationwillbeavailableat www.cel...ayafterwards. , ,PiperJaffrayHealthCareConference...
Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
...Pharma, Inc. (Nasdaq:,GORX) announced today that i...ts of its third fiscal quarter ended December 31, ...ET) with CEO, Mihir Taneja and VP/CFO,Carol Dore-F...erence call,by utilizing the following URL, http:/...?key=PVYY97BW8 thus,avoiding operator assistance ...
... Schering-Plough,Corporation (NYSE: SGP ) today ...on (FDA) has accepted the Peg-IFN (peginterferon a... (sBLA) for review and has,granted Priority Review...h,Stage III melanoma. Schering-Plough submitted it... The Priority Review designation is intended to ex...
...help doctors and clinicians identify best t...ease, BIRMINGHAM, Ala., Jan. 31 Clinical trial r...ation point to the need for more,detailed choleste...nd other,lipids. That,s according to Atherotech, a...xpanded cholesterol test called the VAP (Vertical ...
Other Biology Technology:GeoPharma Announces Third Quarter Conference Call 2FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 2FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 3FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 4FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 5FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 6Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy 2Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy 3
Murashige and Skoog basal salt solution with Gamborg's B5 vitamins, 10X concentrate from Research Organics, Inc.
...ing allows a high-throuput screening of a biologic...r artifitially induced changes in the expression l... studied, classified and compared to each other, c...tized scanning of the hybridized slides in Agilent...
Rabbit Anti-Esa1 Polyclonal Antibody, Unconjugated from Abcam
Goat Anti-Human RORgamma (S-14) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: